Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.37 |
| ▸ | MMP2 | P08253 | 1/20 | 0.37 |
| ▸ | MMP3 | P08254 | 1/20 | 0.37 |
| ▸ | MMP9 | P14780 | 1/20 | 0.37 |
| ▸ | MMP8 | P22894 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.34 |
| ▸ | CHRNB4 | P30926 | 2/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.34 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | PLAAT3 | P53816 | 1/20 | 0.32 |
| ▸ | PLAAT5 | Q96KN8 | 1/20 | 0.32 |
| ▸ | PLAAT2 | Q9NWW9 | 1/20 | 0.32 |
| ▸ | PLAAT4 | Q9UL19 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4297064 | 0.80 | NPC1 (0.44) | MMP1MMP2MMP3MMP9MCL1 | |
| SCHEMBL1900809 | 0.79 | MMP1 (0.37) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL3060269 | 0.76 | MMP1 (0.48) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL2791486 | 0.75 | MMP1 (0.34) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL27871351 | 0.75 | MMP1 (0.34) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL7776613 | 0.73 | FAAH (0.34) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL9298297 | 0.73 | MMP1 (0.33) | MMP1MMP2MMP3MMP9MMP8 | |
| SCHEMBL4301028 | 0.73 | CYP2D6 (0.50) | MMP1MMP8KMT2ACHRNB2CHRNB4 | |
| SCHEMBL967318 | 0.72 | — | — | |
| SCHEMBL8172250 | 0.72 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-100341949-C | 1, 1-dimethyl-3-propanesulfonic indole-1 '- (N, N-dimethyl amino ethylamino) -3' -ethyl-imidazolyl-carbocyanine dye and preparation method and application thereof | RIKAGAKU KENKYUSHO (CN) | 2007-10-10 | — | — | CN | claimed |
| CN-1752149-A | 1, 1-dimethyl-3-propanesulfonic indole-1 '- (N, N-dimethyl amino ethylamino) -3' -ethyl-imidazolyl-carbocyanine dye and preparation method and application thereof | RIKAGAKU KENKYUSHO (CN) | 2006-03-29 | — | — | CN | claimed |
| WO-2022056447-A1 | CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE | GENZYME CORPORATION (US) | 2022-03-17 | — | — | WO | disclosed |
| WO-2010042391-A2 | HIV INTEGRASE INHIBITORS | MERCK SHARP & DOHME CORP. (US) | 2010-04-15 | — | — | WO | disclosed |
| WO-2010042392-A2 | HIV INTEGRASE INHIBITORS | MERCK & CO., INC. (US) | 2010-04-15 | — | — | WO | disclosed |
| US-20090221571-A1 | HIV INTEGRASE INHIBITORS | MSD ITALIA S.R.L. (IT) | 2009-09-03 | — | — | US | disclosed |
| CN-100341949-C | 1, 1-dimethyl-3-propanesulfonic indole-1 '- (N, N-dimethyl amino ethylamino) -3' -ethyl-imidazolyl-carbocyanine dye and preparation method and application thereof | RIKAGAKU KENKYUSHO (CN) | 2007-10-10 | — | — | CN | disclosed |
| CN-1752149-A | 1, 1-dimethyl-3-propanesulfonic indole-1 '- (N, N-dimethyl amino ethylamino) -3' -ethyl-imidazolyl-carbocyanine dye and preparation method and application thereof | RIKAGAKU KENKYUSHO (CN) | 2006-03-29 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090221571-A1 | HIV INTEGRASE INHIBITORS | TYMP, CDK2, TYMS | MMP1 2480/4885MMP2 2733/4885MMP3 3446/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.